Kwabla, M.P
Klett-Tammen, C. J.
Castell, S.
Funding for this research was provided by:
Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
Article History
Received: 7 March 2022
Accepted: 11 July 2022
First Online: 1 August 2022
Declarations
:
: We carried out our study in accordance with the Helsinki Declaration. We obtained ethical approval for the study from both the Ethics Review Committee of the Ghana Health Service (reference number GHS-ERC005/04/18) and the Ethics Committee of the Hannover Medical School in Germany (Nr. 7902_BO_K_2018). We obtained verbal informed consent from all participants of the telephone survey prior to the start of the interview. Verbal consent through telephone surveys has been recommended for studies with minimal risk [CitationRef removed]. Additionally, prior to the start of the interviews, we distributed information sheets about the study to all potential interviewees at their professional meetings in Ghana with the help of the district TB coordinators. The study information was also available online via the research institute’s website. At the start of the interview, a short version of the study information was read for participants to make an informed decision on whether to take part in the study or not.
: Not applicable.
: None declared.